CN118632684A - 一种用于在动物中治疗呼吸系统疾病的可注射药物组合物 - Google Patents

一种用于在动物中治疗呼吸系统疾病的可注射药物组合物 Download PDF

Info

Publication number
CN118632684A
CN118632684A CN202280085114.3A CN202280085114A CN118632684A CN 118632684 A CN118632684 A CN 118632684A CN 202280085114 A CN202280085114 A CN 202280085114A CN 118632684 A CN118632684 A CN 118632684A
Authority
CN
China
Prior art keywords
pharmaceutical composition
injectable pharmaceutical
compound
animals
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280085114.3A
Other languages
English (en)
Chinese (zh)
Inventor
C-C·王
T·迈尔
R·瓦拉斯
J·乌尔里希
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of CN118632684A publication Critical patent/CN118632684A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN202280085114.3A 2021-12-24 2022-12-23 一种用于在动物中治疗呼吸系统疾病的可注射药物组合物 Pending CN118632684A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21217704.2 2021-12-24
EP21217704 2021-12-24
PCT/EP2022/087700 WO2023118557A1 (en) 2021-12-24 2022-12-23 An injectable pharmaceutical composition for the treatment of respiratory diseases in animals

Publications (1)

Publication Number Publication Date
CN118632684A true CN118632684A (zh) 2024-09-10

Family

ID=79601675

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280085114.3A Pending CN118632684A (zh) 2021-12-24 2022-12-23 一种用于在动物中治疗呼吸系统疾病的可注射药物组合物

Country Status (9)

Country Link
US (1) US20250057790A1 (https=)
EP (1) EP4452226A1 (https=)
JP (1) JP2024544415A (https=)
CN (1) CN118632684A (https=)
AR (1) AR128074A1 (https=)
AU (1) AU2022420882A1 (https=)
CA (1) CA3242451A1 (https=)
MX (1) MX2024007862A (https=)
WO (1) WO2023118557A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4208157A1 (en) 2020-09-04 2023-07-12 Elanco Us Inc. Palatable formulations
WO2025133098A2 (en) 2023-12-21 2025-06-26 Intervet International B.V. Processes to make crystalline forms of (s)-n-(3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4- ((4-(((2-methoxyethyl)amino)methyl)phenyl)ethynyl)benzamide salts
WO2025133088A1 (en) 2023-12-21 2025-06-26 Intervet International B.V. Crystalline forms of(s)-n-(3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4- ((4-(((2-methoxyethyl)amino)methyl)phenyl)ethynyl)benzamide salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3740421A (en) 1966-09-19 1973-06-19 Basf Wyandotte Corp Polyoxyethylene-polyoxypropylene aqueous gels
BR112019012861A2 (pt) 2016-12-23 2019-12-10 Intervet Int Bv compostos para o tratamento de doença respiratória bovina ou suína

Also Published As

Publication number Publication date
WO2023118557A1 (en) 2023-06-29
MX2024007862A (es) 2024-07-09
AR128074A1 (es) 2024-03-20
AU2022420882A1 (en) 2024-06-20
JP2024544415A (ja) 2024-11-29
EP4452226A1 (en) 2024-10-30
CA3242451A1 (en) 2023-06-29
US20250057790A1 (en) 2025-02-20

Similar Documents

Publication Publication Date Title
CN118632684A (zh) 一种用于在动物中治疗呼吸系统疾病的可注射药物组合物
KR101102176B1 (ko) 소와 돼지에서의 감염증을 치료하기 위한 조성물 및 방법
EP1626739B1 (en) Compositions comprising florfenicol or a structurally related compound for treating infection in cattle and swine
Stipkovits et al. The efficacy of valnemulin (Econor®) in the control of disease caused by experimental infection of calves with Mycoplasma bovis
JP2006528705A5 (https=)
JP2017536345A (ja) ブタ用飼料中のナラシンの抗ウイルス作用
Dorrestein et al. Clinical pharmacology and pharmacokinetics of flumequine after intravenous, intramuscular and oral administration in pigeons (Columba livid)
RU2678132C2 (ru) Продукт для здоровья собак, содержащий антитела против собачьего парвовируса типа 2
CN113476431B (zh) 一种环三酮衍生物在制备动物用药中的应用
WO2022255959A1 (en) Pharmaceutical compositions of milk fat globules
Couper et al. Treatment of pneumonia in pigs with long‐acting injectable tylosin
Friendship et al. Drug therapy and prophylaxis
Engelken et al. The effect of respiratory vaccine components and route of delivery on weight gain and inflammatory response in suckling beef calves
CN119158025A (zh) 一种用于治疗动物支原体感染的药物制剂及其应用
KR20250106485A (ko) 동물의 피부 질환을 치료하기 위한 조성물
Riviere et al. Tetracyclines
Costa et al. Pseudotuberculosis, how to find the enemy hidden inside doors
Penrith et al. Cases of bacterial pneumonia in cattle and sheep
Dumfries High mortality in lambs due to pasteurellosis
Langford et al. Evidence of anthelmintic resistance in PGE cases in sheep
Curtis et al. THE C-ANADIAN VEEINRJOURC..,.. NAL
EP3473268A1 (en) Combined preparation for parenteral use
Clark SEW: PROGRAM, PROBLEMS, PERFORMANCE, AND POTENTIAL PROFITS
VAN METRE 17 CHAPTER Hemorrhagic Bowel Syndrome
Wu et al. An evaluation of the components of medicated early weaning L. Kirk Clark, DVM, PhD; Michael A. Hill, MS, PhD, MRCVS; Timothy S. Kniffen, DVM, MS; William VanAlstine, DVM, PhD; Gregory Stevenson, DVM, PhD; Kenneth B. Meyer, DVM, MS; Ching

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination